News
Improved Genome Editing with CRISPR-Cas9 CRISPR-Cas9 is a genome editing ... two molecules dramatically increased the performance of “knock-in” gene editing. This strategy, dubbed 2iHDR ...
1d
Futurism on MSNScientists Gene-Hack Spider to Produce Bright-Red SilkResearchers used gene-editing technique CRISPR to modify the DNA sequences of house spiders, causing them to produce red ...
4d
ScienceAlert on MSNWorld's First CRISPR-Edited Spiders Shoot Fluoro Red Silk From Their ButtsBeginning a chain of events that will presumably lead to the origin of our universe's Spider-Man, researchers in Germany have ...
4d
The Daily Galaxy on MSNNo, This Isn’t a Spider-Man Reboot—Scientists Just Made the World’s First Genetically Modified “Spider” That Spins Red Glowing SilkIn a quiet lab in Bayreuth, Germany, a team of researchers has achieved what has long eluded geneticists: modifying the ...
13d
AZ Animals on MSNHouse Spiders Go High-Tech: CRISPR Swaps DNA for Dazzling Red SilkBut a research team from the University of Bayreuth’s Biomaterials division made history with the first-ever successful gene ...
CRISPR-Cas9 is a powerful gene editing system that has revolutionized our ability to treat disease and probe the human genome. CRISPR has been used to edit the genomes of animals, plants, and microbes ...
Nonviral CRISPR-based knock-in of chimeric antigen receptor transgenes into T cells for cell therapy
This linearized template, bound to Cas9-RNP, is then delivered to cells to promote precise knock-in via homology-directed repair. This method significantly enhances the precision and efficiency of ...
The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 gene-editing tool to spiders. Following the genetic modification, the spiders ...
CRISPR/Cas9 allows for precise modifications to the genome, including knock-ins, knockouts, transcriptional activation and repression, and base conversions. This technology has been used to treat ...
The CRISPR-Cas9 patent landscape remains complex and unsettled. The Federal Circuit’s latest decision in University of California v.
In their new study, first author Brent Aulston and colleagues tested this in APP NL-G-F knock-in mice, which start to develop plaques by 2 months of age. They crossed these to mice expressing Cas9 in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results